Shaw and Partners Sticks to Its Buy Rating for Gentrack Group Ltd (GTK)
Shaw and Partners analyst Jules Cooper maintained a Buy rating on Gentrack Group Ltd (GTK – Research Report) today and set a price target of A$11.80. The company's shares closed today at A$10.85.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Cooper is ranked #7517 out of 9519 analysts.
In addition to Shaw and Partners, Gentrack Group Ltd also received a Buy from Canaccord Genuity's Owen Humphries in a report issued on May 5. However, on May 15, UBS maintained a Sell rating on Gentrack Group Ltd (ASX: GTK).
GTK market cap is currently A$1.19B and has a P/E ratio of 130.53.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
Geely chairman says auto industry facing ‘serious overcapacity', Reuters says
Geely's chairman and founder Li Shufu said the global automotive industry is facing 'serious overcapacity' and the company has decided to not build new manufacturing plants or expand production at its current facilities, Reuters reports. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Yahoo
3 hours ago
- Yahoo
ASX Penny Stocks Spotlight Australian Strategic Materials And 2 More Hidden Gems
As the Australian market experiences a gradual downward trend, largely influenced by profit-taking and international tensions, investors are seeking opportunities that can withstand volatility. Penny stocks, though often considered niche investments, still hold potential for growth particularly in smaller or newer companies. When these stocks are backed by solid financial health and fundamentals, they can present underappreciated opportunities for returns without excessive risk. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$70.76M ★★★★★★ GTN (ASX:GTN) A$0.65 A$124.05M ★★★★★★ IVE Group (ASX:IGL) A$2.57 A$396.25M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$441.56M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$725.72M ★★★★★☆ Regal Partners (ASX:RPL) A$2.25 A$756.37M ★★★★★★ Accent Group (ASX:AX1) A$1.845 A$1.11B ★★★★☆☆ Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.37 A$159.91M ★★★★★★ CTI Logistics (ASX:CLX) A$1.815 A$146.19M ★★★★☆☆ Click here to see the full list of 1,001 stocks from our ASX Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Australian Strategic Materials Ltd is an integrated producer of critical metals for advanced and clean technologies in Australia, with a market cap of A$116.96 million. Operations: The company's revenue is primarily derived from its operations in Korea, generating A$0.91 million, and the Dubbo Project, contributing A$1.12 million. Market Cap: A$116.96M Australian Strategic Materials Ltd is pre-revenue, with limited sales of A$1.13 million reported for the half year ending December 2024, and a net loss of A$13.96 million. Despite its unprofitability, ASM has reduced its debt to equity ratio significantly over five years from 319.6% to 8.6%, indicating improved financial management. The company has more cash than total debt and short-term assets exceeding both short- and long-term liabilities, suggesting a stable financial position despite high volatility in share price and less than one year of cash runway based on current free cash flow trends. Click to explore a detailed breakdown of our findings in Australian Strategic Materials' financial health report. Review our historical performance report to gain insights into Australian Strategic Materials' track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Horizon Oil Limited, with a market cap of A$292.55 million, is involved in the exploration, development, and production of oil and gas properties across China, New Zealand, and Australia. Operations: The company's revenue segments include $60.53 million from exploration and development activities in China and $34.26 million from similar operations in New Zealand. Market Cap: A$292.55M Horizon Oil Limited, with a market cap of A$292.55 million, has demonstrated financial resilience despite recent challenges. The company maintains more cash than its total debt, and its interest payments are well-covered by EBIT at 60.8 times coverage. However, Horizon's dividend yield of 15.3% is not supported by earnings or free cash flow, raising sustainability concerns. Profit margins have decreased to 14.1% from last year's 30.3%, and the company experienced negative earnings growth over the past year (-67%). Recent board changes include appointing Catherine Costello as an independent non-executive director to strengthen governance and strategic oversight. Click here and access our complete financial health analysis report to understand the dynamics of Horizon Oil. Explore historical data to track Horizon Oil's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: SHAPE Australia Corporation Limited operates in the construction, fitout, and refurbishment of commercial properties across Australia with a market cap of A$287.93 million. Operations: The company's revenue is primarily derived from its heavy construction segment, which generated A$902.63 million. Market Cap: A$287.93M SHAPE Australia Corporation Limited, with a market cap of A$287.93 million, has shown robust financial performance in the construction sector. Despite an unstable dividend track record, its earnings have grown significantly by 34.9% over the past year, surpassing both industry averages and its 5-year growth rate of 9.3% per annum. The company is debt-free and efficiently manages liabilities with short-term assets of A$209.5 million exceeding both short-term and long-term obligations. SHAPE's Return on Equity stands at an impressive 54.2%, indicating high-quality earnings and effective use of equity capital, although management tenure data remains insufficient for assessment. Jump into the full analysis health report here for a deeper understanding of SHAPE Australia. Explore SHAPE Australia's analyst forecasts in our growth report. Click here to access our complete index of 1,001 ASX Penny Stocks. Ready To Venture Into Other Investment Styles? Outshine the giants: these 25 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ASM ASX:HZN and ASX:SHA. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
3 hours ago
- Yahoo
ASX Penny Stocks Spotlight Australian Strategic Materials And 2 More Hidden Gems
As the Australian market experiences a gradual downward trend, largely influenced by profit-taking and international tensions, investors are seeking opportunities that can withstand volatility. Penny stocks, though often considered niche investments, still hold potential for growth particularly in smaller or newer companies. When these stocks are backed by solid financial health and fundamentals, they can present underappreciated opportunities for returns without excessive risk. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$70.76M ★★★★★★ GTN (ASX:GTN) A$0.65 A$124.05M ★★★★★★ IVE Group (ASX:IGL) A$2.57 A$396.25M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$441.56M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$725.72M ★★★★★☆ Regal Partners (ASX:RPL) A$2.25 A$756.37M ★★★★★★ Accent Group (ASX:AX1) A$1.845 A$1.11B ★★★★☆☆ Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.37 A$159.91M ★★★★★★ CTI Logistics (ASX:CLX) A$1.815 A$146.19M ★★★★☆☆ Click here to see the full list of 1,001 stocks from our ASX Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Australian Strategic Materials Ltd is an integrated producer of critical metals for advanced and clean technologies in Australia, with a market cap of A$116.96 million. Operations: The company's revenue is primarily derived from its operations in Korea, generating A$0.91 million, and the Dubbo Project, contributing A$1.12 million. Market Cap: A$116.96M Australian Strategic Materials Ltd is pre-revenue, with limited sales of A$1.13 million reported for the half year ending December 2024, and a net loss of A$13.96 million. Despite its unprofitability, ASM has reduced its debt to equity ratio significantly over five years from 319.6% to 8.6%, indicating improved financial management. The company has more cash than total debt and short-term assets exceeding both short- and long-term liabilities, suggesting a stable financial position despite high volatility in share price and less than one year of cash runway based on current free cash flow trends. Click to explore a detailed breakdown of our findings in Australian Strategic Materials' financial health report. Review our historical performance report to gain insights into Australian Strategic Materials' track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Horizon Oil Limited, with a market cap of A$292.55 million, is involved in the exploration, development, and production of oil and gas properties across China, New Zealand, and Australia. Operations: The company's revenue segments include $60.53 million from exploration and development activities in China and $34.26 million from similar operations in New Zealand. Market Cap: A$292.55M Horizon Oil Limited, with a market cap of A$292.55 million, has demonstrated financial resilience despite recent challenges. The company maintains more cash than its total debt, and its interest payments are well-covered by EBIT at 60.8 times coverage. However, Horizon's dividend yield of 15.3% is not supported by earnings or free cash flow, raising sustainability concerns. Profit margins have decreased to 14.1% from last year's 30.3%, and the company experienced negative earnings growth over the past year (-67%). Recent board changes include appointing Catherine Costello as an independent non-executive director to strengthen governance and strategic oversight. Click here and access our complete financial health analysis report to understand the dynamics of Horizon Oil. Explore historical data to track Horizon Oil's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: SHAPE Australia Corporation Limited operates in the construction, fitout, and refurbishment of commercial properties across Australia with a market cap of A$287.93 million. Operations: The company's revenue is primarily derived from its heavy construction segment, which generated A$902.63 million. Market Cap: A$287.93M SHAPE Australia Corporation Limited, with a market cap of A$287.93 million, has shown robust financial performance in the construction sector. Despite an unstable dividend track record, its earnings have grown significantly by 34.9% over the past year, surpassing both industry averages and its 5-year growth rate of 9.3% per annum. The company is debt-free and efficiently manages liabilities with short-term assets of A$209.5 million exceeding both short-term and long-term obligations. SHAPE's Return on Equity stands at an impressive 54.2%, indicating high-quality earnings and effective use of equity capital, although management tenure data remains insufficient for assessment. Jump into the full analysis health report here for a deeper understanding of SHAPE Australia. Explore SHAPE Australia's analyst forecasts in our growth report. Click here to access our complete index of 1,001 ASX Penny Stocks. Ready To Venture Into Other Investment Styles? Outshine the giants: these 25 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ASM ASX:HZN and ASX:SHA. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
